Current President and COO, Russell Klinegardner, appointed to succeed Luis Aguilar as President and CEO, Effective January 1, 2024.
HOUSTON, Sept. 1, 2023 /PRNewswire/ — The Health and Safety Council (HASC), a prominent provider of training, occupational health services, and cutting-edge industry technology solutions, is delighted to introduce a strategic leadership transition as part of its ongoing dedication to sustainable expansion and innovation. Commencing on January 1, 2024, Russell Klinegardner will step into the role of President and Chief Executive Officer, succeeding Luis Aguilar. Klinegardner, currently the President and Chief Operating Officer, will also join the Executive Committee of the Board of Directors at that time.
Nick Anagnostou, Vice President HSSE at KBR and the present Chairman of the Board of Directors for HASC, remarks, “This transition signifies a natural progression for HASC. With Russell’s exceptional leadership and extensive industry experience, the Board is fully confident that he will adeptly steer this organization as the new President and CEO. He is a skilled executive characterized by unwavering integrity and an unmatched commitment to excellence. Russell possesses a proven track record of driving success, and under his guidance, HASC will undoubtedly have a promising future marked by innovation.”
Prior to joining HASC, Klinegardner played a pivotal role as a volunteer on the HASC Board of Directors, took on an elected position within the Executive Committee, and notably filled the inaugural two-year role as Chairman of the Board. His career initiation was with Dow Environmental, followed by his tenure at the Brock Group, where he dedicated 20 years to occupying various leadership roles encompassing a wide spectrum of operational and functional capacities, culminating as the Senior Vice President of HSE.
Klinegardner earned a Bachelor’s Degree in Industrial Management and a Master of Business Administration (MBA) from Tulane University. His professional achievements also include being designated as a Board Certified Safety Professional (CSP).
Since joining the company in 2016, Klinegardner has been an integral part of shaping the vision and growth of HASC. Reflecting on this, Klinegardner asserts, “It is a privilege to be designated as the forthcoming President and CEO of HASC. From my tenure on the Board of Directors to my current role within the Health and Safety Council, I am steadfastly committed to propelling innovation and sustainable expansion for HASC. I am honored to contribute to this purposeful and strategic transition into my new role as President and CEO. Together with the capable and talented HASC team, we will persist in our mission to serve and uplift industries both nationally and internationally.”
Aguilar expresses confidence in Klinegardner’s capacity to lead the organization in realizing its vision for growth and innovation at HASC. Aguilar remarks, “Serving as President and CEO of HASC since 2000 has been a privilege. I have collaborated closely with Russell in various capacities for over two decades, and I wholeheartedly endorse him as HASC’s incoming President and CEO. It’s great to see a succession plan come to fruition and I anticipate a seamless transition over the forthcoming months.”
About HASC
The Health and Safety Council (HASC) is a leading training, occupational health and technology association delivering innovative solutions to the industrial sector globally. HASC’s services and expertise enable industry to have access to efficient and effective safety training and quality occupational health everywhere.
Headquartered outside of Houston, Texas, HASC provides over 1.5 million services each year. HASC is a 501(c)3 nonprofit association with a mission of building safe workplaces since 1990. For more information, visit www.hasc.com and follow the Health and Safety Council on LinkedIn.
Marka odkrywa urzekającą nową koncepcję „telefonu torebki”, pokazując model HONOR V Purse, a także prezentuje smartfon HONOR Magic V2 i nowy wariant kolorystyczny HONOR 90.
BERLIN, 1 września 2023 r. /PRNewswire/ — Globalna marka technologiczna HONOR ogłosiła dziś podczas IFA 2023 swoją strategiczną wizję przyszłości smartfonów. Podczas prezentacji otwierającej pod hasłem „Unfold Tomorrow” dyrektor generalny HONOR George Zhao opowiadał o zaangażowaniu marki w uczynienie składanych smartfonów dominującym nurtem dzięki najnowszym zorientowanym na człowieka innowacjom, takim jak najlżejszy i najcieńszy składany do wewnątrz smartfon marki HONOR, Magic V2. Marka pokazała także HONOR V Purse, nową koncepcję, która zamienia składany smartfon w modną torebkę dającą nieskończone możliwości stylizacji i wyrażania siebie.
La marca estrena un nuevo y sorprendente concepto ‘Phone-to-Purse’ con la presentación de HONOR V Purse, muestra HONOR Magic V2 y lanza una nueva variante de color para HONOR 90
BERLÍN, 1 de septiembre de 2023 /PRNewswire/ — La marca de tecnología global HONOR anunció hoy su visión estratégica para el futuro de los teléfonos inteligentes en IFA 2023. Durante su sesión magistral titulada “Unfold Tomorrow” el consejero delegado de HONOR, George Zhao, describió el compromiso de la marca de popularizar los teléfonos inteligentes plegables, con sus últimas innovaciones centradas en el ser humano, incluido el teléfono inteligente plegable interior más ligero y delgado de HONOR, el Magic V2. La marca también presentó el HONOR V Purse, un nuevo concepto que reinventa un teléfono inteligente plegable como un bolso portátil y vanguardista, que ofrece infinitas posibilidades de estilo y autoexpresión.
A state-of-the-art facility with dedicated medical professionals who put the patient’s health and wellness above all else is set to open its doors on September 7.
VENICE, Fla., Sept. 1, 2023 /PRNewswire/ — Today marks the launch of a new, freedom-based health and wellness clinic in the Sunshine State. We The People Health and Wellness Center is proud to unveil its visionary Direct Primary Care (DPC) clinic in Venice.
IV and Red Light Therapy Lounge at We The People Health and Wellness Center Venice FL
The new state of the art We The People Health and Wellness Center, Venice FL
The global plant-based excipients market is projected to experience significant growth during the forecast period due to the rising demand for natural and sustainable products across various industries, including pharmaceuticals.
Plant-based excipients offer a more eco-friendly and sustainable alternative to traditional excipients derived from non-renewable sources like petroleum. This shift is driven by consumer and government focus on sustainability, leading to new opportunities for the global plant-based excipients market.
Key Drivers:
Growing Demand for Sustainable Products: Consumers are increasingly concerned about the environmental impact of products and are seeking sustainable alternatives. This trend is expected to drive the demand for plant-based excipients.
Safer and More Natural Ingredients: Plant-based excipients derived from sources such as algae, starches, cellulose, gums, and proteins are considered safer and less likely to cause adverse reactions in patients compared to synthetic excipients.
Regulatory Support: Favorable regulations and policies, such as FDA’s GRAS list and European Pharmacopoeia standards, encourage the use of plant-based excipients in pharmaceuticals.
Research and Development: Increased research in plant-based excipients has led to innovations in their properties and applications, further promoting their adoption.
Trends and Opportunities:
Combining Natural Ingredients: There is a trend towards combining plant-based excipients with other natural ingredients, enhancing the quality and sustainability of pharmaceutical products.
Supportive Regulations: Regulations like FDA’s GRAS list and European Pharmacopoeia standards support the use of plant-based excipients in pharmaceutical formulations.
Increasing Research: Ongoing research focuses on developing plant-based excipients like alginate and cellulose to enhance drug solubility, stability, and bioavailability.
Companies Mentioned:
Roquette Freres SA
EVONIK Industries, Inc.
DFE Pharma GmbH & Co.KG
Lonza Group
BASF SE
Novartis International AG
FMC Corporation
JRS Pharma LP
Report Scope:
The report covers various segments of the global plant-based excipients market, including types (carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, others), applications (binders & diluents, glidants, lubricants & disintegrants, film-forming & coating agents, plasticizers, suspending agents, others), and regions (North America, Europe, Asia Pacific, South America, Middle East & Africa).
In conclusion, the global plant-based excipients market is driven by the demand for sustainable and eco-friendly products, leading to increased use of plant-based excipients in pharmaceuticals. Supportive regulations, research activities, and the trend of combining natural ingredients are further propelling the growth of this market.
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ATLANTA, Sept. 1, 2023 /PRNewswire/ — The Board of Trustees of each of the Invesco closed-end funds listed below today declared the following dividends.
EX-DATE
9/14/23
RECORD DATE 9/15/23
REINVEST DATE 9/29/23
PAYABLE DATE 9/29/23
Name of Closed-End Management Investment Company
Ticker
Monthly Dividend Amount Per Share
Change From Prior Distribution
Invesco Advantage Municipal Income Trust II
VKI
$0.0309
-0.0012
Invesco Bond Fund
VBF
$0.0660
+0.0025
Invesco California Value Municipal Income Trust
VCV
$0.0320
-0.0015
Invesco High Income 2023 Target Term Fund
IHIT
$0.0200
-0.0150
Invesco High Income 2024 Target Term Fund
IHTA
$0.0330
–
Invesco Municipal Income Opportunities Trust
OIA
$0.0265
–
Invesco Municipal Opportunity Trust
VMO
$0.0340
-0.0018
Invesco Municipal Trust
VKQ
$0.0346
-0.0018
Invesco Pennsylvania Value Municipal Income Trust
VPV
$0.0305
–
Invesco Quality Municipal Income Trust
IQI
$0.0358
-0.0014
Invesco Trust for Investment Grade Municipals
VGM
$0.0342
-0.0019
Invesco Trust for Investment Grade New York Municipals
VTN
$0.0320
-0.0011
Invesco Value Municipal Income Trust
IIM
$0.0441
-0.0017
Form 1099-DIV for the calendar year will report distributions for federal income tax purposes. The Fund’s annual report to shareholders will include information regarding the tax character of Fund distributions for the fiscal year.
1 A portion of this distribution is estimated to be from a return of principal rather than net income. The Section 19 notice referenced below provides more information and can be found on the Invesco website at www.invesco.com.
The final determination of the source and tax characteristics of all distributions in 2023will be made after the end of the year.
In order to comply with the requirements of Section 19 of the Investment Company Act of 1940, each Fund will provide its shareholders of record on the record date with a Section 19 Notice disclosing the sources of its dividend payment when a distribution includes anything other than net investment income. The Section 19 Notice is not provided for tax reporting purposes but for informational purposes only. If applicable, this Section 19 Notice information can be found on the Funds’ website at www.invesco.com
The amount of dividends paid by each fund may vary from time to time. Past amounts of dividends are no guarantee of future dividend payment amounts.
Investing involves risk and it is possible to lose money on any investment in the funds.
For additional information, shareholders of the closed end fund may contact Jeaneen Terrio at 212-278-9205, [email protected].
About Invesco Ltd. Invesco Ltd. is a global independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. Our distinctive investment teams deliver a comprehensive range of active, passive and alternative investment capabilities. With offices in more than 20 countries, Invesco managed $1.5 trillion in assets on behalf of clients worldwide as of June 30, 2023. For more information, visit Invesco.com.
Invesco Distributors, Inc. is the US distributor for Invesco Ltd. It is an indirect, wholly owned subsidiary of Invesco Ltd.
Note: There is no assurance that a closed-end fund will achieve its investment objective. Shares are bought on the secondary market and may trade at a discount or premium to NAV. Regular brokerage commissions apply.
NOT A DEPOSIT l NOT FDIC INSURED l NOT GUARANTEED BY THE BANK | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY
